CANTON, Conn., May 11, 2026 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a leader in custom cranial implants, today reported its financial results for the first quarter ended March 31, 2026. The company delivered excellent performance, with strong revenue growth and…